
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $3B | $3.7B | $3.8B | $4.2B | |
Revenue Growth (YoY) | 2.74% | 16.98% | 25.33% | 3.27% | 9.2% | |
Cost of Revenues | $853.9M | $1B | $1.4B | $1.5B | $1.7B | |
Gross Profit | $1.7B | $1.9B | $2.3B | $2.3B | $2.5B | |
Gross Profit Margin | 66.26% | 65.47% | 62.67% | 60.4% | 60.01% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $829.7M | $909M | $1.2B | $1.2B | $1.2B | |
Other Inc / (Exp) | $11.8M | -$17.6M | -$6M | -$484.2M | -$75.4M | |
Operating Expenses | $1.2B | $1.3B | $1.7B | $1.7B | $1.8B | |
Operating Income | $500.2M | $651.9M | $626.4M | $617.9M | $733.4M | |
Net Interest Expenses | $122.6M | $128.8M | $237.2M | $279M | $256.9M | |
EBT. Incl. Unusual Items | $389.5M | $505.6M | $383M | -$145.3M | $401.1M | |
Earnings of Discontinued Ops. | $49.8M | $1B | $17.4M | -$700K | -- | |
Income Tax Expense | $83.7M | $131.9M | $118.9M | $44.7M | $98.8M | |
Net Income to Company | $305.7M | $373.7M | $264.1M | -$190.1M | $302.3M | |
Minority Interest in Earnings | -$12.4M | -$15M | -$15.2M | -$15.4M | -$18M | |
Net Income to Common Excl Extra Items | $343.2M | $1.4B | $266.3M | -$206.2M | $284.4M | |
Basic EPS (Cont. Ops) | $1.81 | $7.26 | $1.38 | -$1.07 | $1.46 | |
Diluted EPS (Cont. Ops) | $1.79 | $7.20 | $1.38 | -$1.07 | $1.45 | |
Weighted Average Basic Share | $189.9M | $191.4M | $192.5M | $193.4M | $194.4M | |
Weighted Average Diluted Share | $192.2M | $193M | $193.1M | $193.4M | $196.7M | |
EBITDA | $862.5M | $995.2M | $1.1B | $667.3M | $1.2B | |
EBIT | $515.7M | $618.2M | $613.9M | $142.9M | $666.3M | |
Revenue (Reported) | $2.5B | $3B | $3.7B | $3.8B | $4.2B | |
Operating Income (Reported) | $500.2M | $651.9M | $626.4M | $617.9M | $733.4M | |
Operating Income (Adjusted) | $515.7M | $618.2M | $613.9M | $142.9M | $666.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $698.9M | $921.3M | $940.3M | $1B | $1.1B | |
Revenue Growth (YoY) | 1.64% | 31.82% | 2.06% | 8.6% | 7.3% | |
Cost of Revenues | $226.8M | $298M | $380.8M | $406.3M | $445.6M | |
Gross Profit | $472.1M | $623.3M | $559.5M | $614.9M | $650.1M | |
Gross Profit Margin | 67.55% | 67.65% | 59.5% | 60.21% | 59.33% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $219.1M | $359.5M | $284.6M | $305.6M | $256.8M | |
Other Inc / (Exp) | $3.4M | -$1.9M | -$2M | -$25.5M | -$12.7M | |
Operating Expenses | $308.5M | $488.3M | $414.3M | $439.6M | $395.7M | |
Operating Income | $163.6M | $135M | $145.2M | $175.3M | $254.4M | |
Net Interest Expenses | $25.9M | $56.4M | $67.7M | $67M | $47.9M | |
EBT. Incl. Unusual Items | $141M | $76.7M | $75.6M | $83M | $193.8M | |
Earnings of Discontinued Ops. | $13.3M | -$400K | -$100K | -- | -- | |
Income Tax Expense | $23.7M | $24.4M | $18.6M | $13M | $41M | |
Net Income to Company | $130.6M | $52.3M | $56.9M | $70M | $152.7M | |
Minority Interest in Earnings | -$2.7M | -$3.7M | -$4.3M | -$4.9M | -$4.7M | |
Net Income to Common Excl Extra Items | $127.9M | $48.3M | $52.6M | $65.1M | $148.1M | |
Basic EPS (Cont. Ops) | $0.67 | $0.25 | $0.27 | $0.34 | $0.76 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.25 | $0.27 | $0.33 | $0.75 | |
Weighted Average Basic Share | $190.9M | $192.1M | $193M | $194.1M | $195.1M | |
Weighted Average Diluted Share | $192.5M | $193.2M | $193.9M | $195.3M | $197.3M | |
EBITDA | $256.2M | $255.7M | $277.1M | $285.7M | $388.8M | |
EBIT | $166.8M | $126.9M | $147.4M | $151.7M | $249.9M | |
Revenue (Reported) | $698.9M | $921.3M | $940.3M | $1B | $1.1B | |
Operating Income (Reported) | $163.6M | $135M | $145.2M | $175.3M | $254.4M | |
Operating Income (Adjusted) | $166.8M | $126.9M | $147.4M | $151.7M | $249.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $3.2B | $3.7B | $3.9B | $4.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $855.6M | $1.1B | $1.4B | $1.5B | $1.7B | |
Gross Profit | $1.7B | $2.1B | $2.3B | $2.4B | $2.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $813.5M | $1B | $1.1B | $1.2B | $1.2B | |
Other Inc / (Exp) | $19.8M | -$23M | -$6.2M | -$507.7M | -$62.6M | |
Operating Expenses | $1.2B | $1.5B | $1.6B | $1.7B | $1.7B | |
Operating Income | $527M | $623.5M | $636.5M | $648.1M | $812.5M | |
Net Interest Expenses | $112.9M | $159.3M | $248.6M | $278.2M | $237.8M | |
EBT. Incl. Unusual Items | $433.9M | $441.2M | $381.8M | -$137.9M | $511.9M | |
Earnings of Discontinued Ops. | $13.3M | $1B | $17.7M | -$700K | -- | |
Income Tax Expense | $85.2M | $132.6M | $113.2M | $39.1M | $126.8M | |
Net Income to Company | $362M | $295.4M | $268.7M | -$177M | $385M | |
Minority Interest in Earnings | -$11M | -$15.9M | -$15.8M | -$16M | -$17.9M | |
Net Income to Common Excl Extra Items | $400.9M | $1.3B | $270.7M | -$193.8M | $367.3M | |
Basic EPS (Cont. Ops) | $2.10 | $6.83 | $1.42 | -$1.00 | $1.89 | |
Diluted EPS (Cont. Ops) | $2.08 | $6.77 | $1.41 | -$1.01 | $1.88 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $894.2M | $994.6M | $1.2B | $675.8M | $1.3B | |
EBIT | $548.3M | $578.2M | $634.3M | $147.1M | $764.5M | |
Revenue (Reported) | $2.5B | $3.2B | $3.7B | $3.9B | $4.3B | |
Operating Income (Reported) | $527M | $623.5M | $636.5M | $648.1M | $812.5M | |
Operating Income (Adjusted) | $548.3M | $578.2M | $634.3M | $147.1M | $764.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $698.9M | $921.3M | $940.3M | $1B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $226.8M | $298M | $380.8M | $406.3M | $445.6M | |
Gross Profit | $472.1M | $623.3M | $559.5M | $614.9M | $650.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $219.1M | $359.5M | $284.6M | $305.6M | $256.8M | |
Other Inc / (Exp) | $3.4M | -$1.9M | -$2M | -$25.5M | -$12.7M | |
Operating Expenses | $308.5M | $488.3M | $414.3M | $439.6M | $395.7M | |
Operating Income | $163.6M | $135M | $145.2M | $175.3M | $254.4M | |
Net Interest Expenses | $25.9M | $56.4M | $67.7M | $67M | $47.9M | |
EBT. Incl. Unusual Items | $141M | $76.7M | $75.6M | $83M | $193.8M | |
Earnings of Discontinued Ops. | $13.3M | -$400K | -$100K | -- | -- | |
Income Tax Expense | $23.7M | $24.4M | $18.6M | $13M | $41M | |
Net Income to Company | $130.6M | $52.3M | $56.9M | $70M | $152.7M | |
Minority Interest in Earnings | -$2.7M | -$3.7M | -$4.3M | -$4.9M | -$4.7M | |
Net Income to Common Excl Extra Items | $127.9M | $48.3M | $52.6M | $65.1M | $148.1M | |
Basic EPS (Cont. Ops) | $0.67 | $0.25 | $0.27 | $0.34 | $0.76 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.25 | $0.27 | $0.33 | $0.75 | |
Weighted Average Basic Share | $190.9M | $192.1M | $193M | $194.1M | $195.1M | |
Weighted Average Diluted Share | $192.5M | $193.2M | $193.9M | $195.3M | $197.3M | |
EBITDA | $256.2M | $255.7M | $277.1M | $285.7M | $388.8M | |
EBIT | $166.8M | $126.9M | $147.4M | $151.7M | $249.9M | |
Revenue (Reported) | $698.9M | $921.3M | $940.3M | $1B | $1.1B | |
Operating Income (Reported) | $163.6M | $135M | $145.2M | $175.3M | $254.4M | |
Operating Income (Adjusted) | $166.8M | $126.9M | $147.4M | $151.7M | $249.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $492.7M | $1.8B | $585.3M | $476.2M | $679.5M | |
Short Term Investments | $3.2M | $3.1M | $2.6M | $2.7M | $2.5M | |
Accounts Receivable, Net | $392.8M | $558M | $602.2M | $723M | $798.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $84.3M | $136.2M | $145.1M | $145.4M | $126M | |
Other Current Assets | $66.8M | $87.1M | $115M | $127.8M | $105.2M | |
Total Current Assets | $1.5B | $2.6B | $1.5B | $1.5B | $1.8B | |
Property Plant And Equipment | $279.5M | $392.9M | $345.7M | $298.2M | $259.4M | |
Long-Term Investments | $133.6M | $240.5M | $265.9M | $291.4M | $279.9M | |
Goodwill | $3.2B | $5.5B | $5.6B | $5.2B | $5.1B | |
Other Intangibles | $2.2B | $3.8B | $3.7B | $3.5B | $3.3B | |
Other Long-Term Assets | $29.1M | $51.3M | $61.5M | $93.7M | $121.9M | |
Total Assets | $7.3B | $12.6B | $11.7B | $11.1B | $11B | |
Accounts Payable | $188.4M | $270.2M | $250.4M | $251.3M | $294.6M | |
Accrued Expenses | $223.9M | $365.5M | $333.5M | $428.9M | $407.1M | |
Current Portion Of Long-Term Debt | $55.5M | $114.6M | $114.6M | $89.6M | $70.6M | |
Current Portion Of Capital Lease Obligations | $16.9M | $38.4M | $33.7M | $26.2M | $22M | |
Other Current Liabilities | $98M | $83.6M | $53.4M | $71.4M | $94.2M | |
Total Current Liabilities | $669.8M | $1.4B | $905.5M | $1B | $1.1B | |
Long-Term Debt | $3.4B | $6.3B | $5.6B | $5.3B | $5.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.7B | $8.6B | $7.4B | $7B | $6.7B | |
Common Stock | $2M | $2M | $2M | $2M | $2M | |
Other Common Equity Adj | -$272.1M | -$285.4M | -$284.5M | -$260.9M | -$367.2M | |
Common Equity | $2.5B | $3.9B | $4.2B | $4B | $4.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $95.9M | $98.1M | $99.5M | $97.3M | $101.8M | |
Total Equity | $2.6B | $4B | $4.3B | $4.1B | $4.3B | |
Total Liabilities and Equity | $7.3B | $12.6B | $11.7B | $11.1B | $11B | |
Cash and Short Terms | $495.9M | $1.8B | $587.9M | $478.9M | $682M | |
Total Debt | $3.5B | $6.4B | $5.7B | $5.3B | $5.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $433M | $1.3B | $439M | $433.6M | $609.9M | |
Short Term Investments | $3.3M | $3M | $2.7M | $2.6M | $2.6M | |
Accounts Receivable, Net | $488.1M | $588.9M | $652.6M | $774.6M | $882.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $115.7M | $155.3M | $175.7M | $146.9M | $143.8M | |
Other Current Assets | $82.1M | $118.5M | $111.1M | $65.2M | $88.5M | |
Total Current Assets | $1.1B | $2.2B | $1.4B | $1.4B | $1.8B | |
Property Plant And Equipment | $279.4M | $379.3M | $329.3M | $293.8M | $258.5M | |
Long-Term Investments | $139.9M | $244.6M | $302.4M | $302.8M | $275.8M | |
Goodwill | $3.5B | $5.5B | $5.6B | $5.2B | $5.2B | |
Other Intangibles | $2.2B | $3.7B | $3.6B | $3.5B | $3.2B | |
Other Long-Term Assets | $43M | $63.3M | $77.7M | $128.2M | $131.5M | |
Total Assets | $7.3B | $12.2B | $11.6B | $11B | $10.9B | |
Accounts Payable | $203.5M | $260.3M | $298.4M | $281.3M | $325.6M | |
Accrued Expenses | $172.1M | $248.2M | $225.9M | $253.2M | $183.8M | |
Current Portion Of Long-Term Debt | $62.7M | $114.6M | $114.6M | $77.5M | $70.6M | |
Current Portion Of Capital Lease Obligations | $14.1M | $37.9M | $34.1M | $24.6M | $22.9M | |
Other Current Liabilities | $85.7M | $57.3M | $59.3M | $78.6M | $106.4M | |
Total Current Liabilities | $630.2M | $1.2B | $878.4M | $861M | $888.5M | |
Long-Term Debt | $3.3B | $5.8B | $5.5B | $5.3B | $5.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5B | $8.1B | $7.2B | $6.8B | $6.5B | |
Common Stock | $2M | $2M | $2M | $2M | $2M | |
Other Common Equity Adj | -$260.3M | -$184.7M | -$282.2M | -$262.8M | -$355.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $97.6M | $101.7M | $103.2M | $101.9M | $106.7M | |
Total Equity | $2.8B | $4.1B | $4.3B | $4.2B | $4.5B | |
Total Liabilities and Equity | $7.3B | $12.2B | $11.6B | $11B | $10.9B | |
Cash and Short Terms | $436.3M | $1.3B | $441.7M | $436.2M | $612.5M | |
Total Debt | $3.4B | $5.9B | $5.6B | $5.3B | $5.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $305.7M | $373.7M | $264.1M | -$190.1M | $302.3M | |
Depreciation & Amoritzation | $346.8M | $377M | $519M | $524.4M | $537.8M | |
Stock-Based Compensation | $44.3M | $69.2M | $82.8M | $100.3M | $121.2M | |
Change in Accounts Receivable | -$15.6M | -$36.2M | -$37.5M | -$135.1M | -$105.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $787.6M | $808.3M | $297.2M | $645.4M | $832.5M | |
Capital Expenditures | $205.6M | $224.2M | $298.2M | $310.7M | $315.8M | |
Cash Acquisitions | -$66.5M | -$3.7B | -$524.3M | -$36.9M | $1.8M | |
Cash From Investing | -$267.2M | -$2.2B | -$723.9M | -$318.9M | -$307.4M | |
Dividends Paid (Ex Special Dividend) | -$57.6M | -$69.8M | -$77.8M | -$81.8M | -$82.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $3.7B | -- | $655.8M | $1.8B | |
Long-Term Debt Repaid | -$208.8M | -$780.8M | -$714.6M | -$997.7M | -$2B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$53.4M | -$149M | -$46.8M | -$38.2M | -$59M | |
Cash From Financing | -$296.9M | $2.8B | -$820.5M | -$438.8M | -$308.7M | |
Beginning Cash (CF) | $273.6M | $492.7M | $1.8B | $585.3M | $476.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $223.5M | $1.4B | -$1.2B | -$112.3M | $216.4M | |
Ending Cash (CF) | $492.7M | $1.8B | $585.3M | $476.2M | $679.5M | |
Levered Free Cash Flow | $582M | $584.1M | -$1M | $334.7M | $516.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $130.6M | $52.3M | $56.9M | $70M | $152.7M | |
Depreciation & Amoritzation | $89.4M | $128.8M | $129.7M | $134M | $138.9M | |
Stock-Based Compensation | $17M | $20.9M | $22.1M | $24.1M | $30.3M | |
Change in Accounts Receivable | -$32.8M | -$32.6M | -$56.7M | -$60.7M | -$88.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $144.8M | $11.2M | $77.4M | $54M | $52.5M | |
Capital Expenditures | $40.7M | $58.6M | $66.5M | $62.4M | $68.4M | |
Cash Acquisitions | -$10M | -$14.8M | -$31.9M | -$1.2M | -$20M | |
Cash From Investing | -$71.9M | -$91M | -$103.6M | -$62.4M | -$86.6M | |
Dividends Paid (Ex Special Dividend) | -$15M | -$19M | -$20.6M | -$20.8M | -$22.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $264.1M | -- | |
Long-Term Debt Repaid | -$99.6M | -$428.6M | -$103.6M | -$271.7M | -$17.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$5.4M | |
Other Financing Activities | -$27.7M | -$28.7M | -$7.6M | -$15.3M | -$5.5M | |
Cash From Financing | -$132.2M | -$467.6M | -$122M | -$31.3M | -$40.6M | |
Beginning Cash (CF) | $492.7M | $1.8B | $585.3M | $476.2M | $679.5M | |
Foreign Exchange Rate Adjustment | -$600K | $1.8M | $1.9M | -$2.9M | $5.1M | |
Additions / Reductions | -$59.4M | -$547.4M | -$148.2M | -$39.7M | -$74.7M | |
Ending Cash (CF) | $432.7M | $1.3B | $439M | $433.6M | $609.9M | |
Levered Free Cash Flow | $104.1M | -$47.4M | $10.9M | -$8.4M | -$15.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $362M | $295.4M | $268.7M | -$177M | $385M | |
Depreciation & Amoritzation | $345.9M | $416.4M | $519.9M | $528.7M | $542.7M | |
Stock-Based Compensation | $56.4M | $73.1M | $84M | $102.3M | $127.4M | |
Change in Accounts Receivable | -$7.8M | -$36M | -$61.6M | -$139.1M | -$133.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $806.9M | $674.7M | $363.4M | $622M | $831M | |
Capital Expenditures | $204.3M | $242.1M | $306.1M | $306.6M | $321.8M | |
Cash Acquisitions | -$71.3M | -$3.7B | -$541.4M | -$6.2M | -$17M | |
Cash From Investing | -$313.6M | -$2.2B | -$736.5M | -$277.7M | -$331.6M | |
Dividends Paid (Ex Special Dividend) | -$57.9M | -$73.8M | -$79.4M | -$82M | -$84.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $919.9M | $1.5B | |
Long-Term Debt Repaid | -$294.6M | -$1.1B | -$389.6M | -$1.2B | -$1.7B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$49M | -$150M | -$25.7M | -$45.9M | -$49.2M | |
Cash From Financing | -$379.4M | $2.4B | -$474.9M | -$348.1M | -$318M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $113.8M | $869.7M | -$848M | -$3.8M | $181.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $602.6M | $432.6M | $57.3M | $315.4M | $509.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $130.6M | $52.3M | $56.9M | $70M | $152.7M | |
Depreciation & Amoritzation | $89.4M | $128.8M | $129.7M | $134M | $138.9M | |
Stock-Based Compensation | $17M | $20.9M | $22.1M | $24.1M | $30.3M | |
Change in Accounts Receivable | -$32.8M | -$32.6M | -$56.7M | -$60.7M | -$88.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $144.8M | $11.2M | $77.4M | $54M | $52.5M | |
Capital Expenditures | $40.7M | $58.6M | $66.5M | $62.4M | $68.4M | |
Cash Acquisitions | -$10M | -$14.8M | -$31.9M | -$1.2M | -$20M | |
Cash From Investing | -$71.9M | -$91M | -$103.6M | -$62.4M | -$86.6M | |
Dividends Paid (Ex Special Dividend) | -$15M | -$19M | -$20.6M | -$20.8M | -$22.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $264.1M | -- | |
Long-Term Debt Repaid | -$99.6M | -$428.6M | -$103.6M | -$271.7M | -$17.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$5.4M | |
Other Financing Activities | -$27.7M | -$28.7M | -$7.6M | -$15.3M | -$5.5M | |
Cash From Financing | -$132.2M | -$467.6M | -$122M | -$31.3M | -$40.6M | |
Beginning Cash (CF) | $492.7M | $1.8B | $585.3M | $476.2M | $679.5M | |
Foreign Exchange Rate Adjustment | -$600K | $1.8M | $1.9M | -$2.9M | $5.1M | |
Additions / Reductions | -$59.4M | -$547.4M | -$148.2M | -$39.7M | -$74.7M | |
Ending Cash (CF) | $432.7M | $1.3B | $439M | $433.6M | $609.9M | |
Levered Free Cash Flow | $104.1M | -$47.4M | $10.9M | -$8.4M | -$15.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.